Collectively, our findings strengthen the concept that a “METTL3–m6A–lncRNA–reader” cascade constitutes a critical layer of post-stroke regulation and highlight lncRNA-centred epitranscriptomic networks as promising therapeutic targets for cerebral ischemia–reperfusion injury. The gene discussed is METTL3; the disease is brain ischemia.